146 related articles for article (PubMed ID: 22244876)
1. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration.
Ahn H; Kim JM; Lee K; Kim H; Jeong D
Biochem Biophys Res Commun; 2012 Feb; 418(1):144-8. PubMed ID: 22244876
[TBL] [Abstract][Full Text] [Related]
2. Evidence that activation of ASIC1a by acidosis increases osteoclast migration and adhesion by modulating integrin/Pyk2/Src signaling pathway.
Li X; Ye JX; Xu MH; Zhao MD; Yuan FL
Osteoporos Int; 2017 Jul; 28(7):2221-2231. PubMed ID: 28462470
[TBL] [Abstract][Full Text] [Related]
3. Integrin-mediated signaling in the regulation of osteoclast adhesion and activation.
Duong LT; Rodan GA
Front Biosci; 1998 Aug; 3():d757-68. PubMed ID: 9682033
[TBL] [Abstract][Full Text] [Related]
4. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase.
Duong LT; Lakkakorpi PT; Nakamura I; Machwate M; Nagy RM; Rodan GA
J Clin Invest; 1998 Sep; 102(5):881-92. PubMed ID: 9727056
[TBL] [Abstract][Full Text] [Related]
5. Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.
Adapala NS; Barbe MF; Tsygankov AY; Lorenzo JA; Sanjay A
J Cell Biochem; 2014 Jul; 115(7):1277-89. PubMed ID: 24470255
[TBL] [Abstract][Full Text] [Related]
6. Src kinase activity is essential for osteoclast function.
Miyazaki T; Sanjay A; Neff L; Tanaka S; Horne WC; Baron R
J Biol Chem; 2004 Apr; 279(17):17660-6. PubMed ID: 14739300
[TBL] [Abstract][Full Text] [Related]
7. Peptidomimetic antagonists of alphavbeta3 inhibit bone resorption by inhibiting osteoclast bone resorptive activity, not osteoclast adhesion to bone.
Carron CP; Meyer DM; Engleman VW; Rico JG; Ruminski PG; Ornberg RL; Westlin WF; Nickols GA
J Endocrinol; 2000 Jun; 165(3):587-98. PubMed ID: 10828842
[TBL] [Abstract][Full Text] [Related]
8. Dynamin forms a Src kinase-sensitive complex with Cbl and regulates podosomes and osteoclast activity.
Bruzzaniti A; Neff L; Sanjay A; Horne WC; De Camilli P; Baron R
Mol Biol Cell; 2005 Jul; 16(7):3301-13. PubMed ID: 15872089
[TBL] [Abstract][Full Text] [Related]
9. Myristoleic acid inhibits osteoclast formation and bone resorption by suppressing the RANKL activation of Src and Pyk2.
Kwon JO; Jin WJ; Kim B; Kim HH; Lee ZH
Eur J Pharmacol; 2015 Dec; 768():189-98. PubMed ID: 26528796
[TBL] [Abstract][Full Text] [Related]
10. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin.
Faccio R; Novack DV; Zallone A; Ross FP; Teitelbaum SL
J Cell Biol; 2003 Aug; 162(3):499-509. PubMed ID: 12900398
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin posttranslational modifications, possibly phosphorylation, are required for in vitro bone resorption but not osteoclast adhesion.
Razzouk S; Brunn JC; Qin C; Tye CE; Goldberg HA; Butler WT
Bone; 2002 Jan; 30(1):40-7. PubMed ID: 11792563
[TBL] [Abstract][Full Text] [Related]
12. Osteoprotegerin induces podosome disassembly in osteoclasts through calcium, ERK, and p38 MAPK signaling pathways.
Zhao H; Liu X; Zou H; Dai N; Yao L; Gao Q; Liu W; Gu J; Yuan Y; Bian J; Liu Z
Cytokine; 2015 Feb; 71(2):199-206. PubMed ID: 25461399
[TBL] [Abstract][Full Text] [Related]
13. Notch2 signaling promotes osteoclast resorption via activation of PYK2.
Jin WJ; Kim B; Kim JW; Kim HH; Ha H; Lee ZH
Cell Signal; 2016 May; 28(5):357-365. PubMed ID: 26829213
[TBL] [Abstract][Full Text] [Related]
14. Src blockage by siRNA inhibits VEGF-induced vascular hyperpemeability and osteoclast activity - an in vitro mechanism study for preventing destructive repair of osteonecrosis.
Cao HJ; Zheng LZ; Wang N; Wang LY; Li Y; Li D; Lai YX; Wang XL; Qin L
Bone; 2015 May; 74():58-68. PubMed ID: 25554601
[TBL] [Abstract][Full Text] [Related]
15. Regulatory mechanism of osteoclast activation.
Nakamura I; Rodan GA; Duong LT
J Electron Microsc (Tokyo); 2003; 52(6):527-33. PubMed ID: 14756240
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase Cgamma2 modulates integrin signaling in the osteoclast by affecting the localization and activation of Src kinase.
Epple H; Cremasco V; Zhang K; Mao D; Longmore GD; Faccio R
Mol Cell Biol; 2008 Jun; 28(11):3610-22. PubMed ID: 18378693
[TBL] [Abstract][Full Text] [Related]
17. Podosomes are dispensable for osteoclast differentiation and migration.
Touaitahuata H; Planus E; Albiges-Rizo C; Blangy A; Pawlak G
Eur J Cell Biol; 2013; 92(4-5):139-49. PubMed ID: 23598086
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of osteoclast activation by phloretin through disturbing αvβ3 integrin-c-Src pathway.
Lee EJ; Kim JL; Gong JH; Park SH; Kang YH
Biomed Res Int; 2015; 2015():680145. PubMed ID: 25834823
[TBL] [Abstract][Full Text] [Related]
19. Association of leupaxin with Src in osteoclasts.
Sahu SN; Khadeer MA; Robertson BW; Núñez SM; Bai G; Gupta A
Am J Physiol Cell Physiol; 2007 Jan; 292(1):C581-90. PubMed ID: 16914530
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a-Ror2 signaling.
Uehara S; Udagawa N; Mukai H; Ishihara A; Maeda K; Yamashita T; Murakami K; Nishita M; Nakamura T; Kato S; Minami Y; Takahashi N; Kobayashi Y
Sci Signal; 2017 Aug; 10(494):. PubMed ID: 28851822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
